Baxter International | BAX - Capitaux Propres Et Réserves

Prix De L'Action
17.15
Variation Quotidienne
-0.15 -0.87%
Mensuellement
-4.99%
Annuel
-38.40%
Q2 Prévisions
16.68




Capitaux Propres Et Réserves Changement Date
Abbott USD 52.13B 1.3B 2025-12
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 448.23M 9.54M 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Avanos Medical USD 778.2M 200K 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Fresenius EUR 18.62B 320M 2025-09
Globus Medical USD 4.57B 174.42M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
ICU Medical USD 2.12B 3.42M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
J&J USD 78.47B 0 2025-09
Laboratory Of America USD 8.62B 93.2M 2025-12
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.58B 54.9M 2025-12
Quest Diagnostics USD 7.17B 88M 2025-12
Smith & Nephew USD 5.54B 331M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Terumo JPY 1.52T 84.79B 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12